Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu,

Slides:



Advertisements
Similar presentations
Volume 39, Issue 3, Pages (September 2013)
Advertisements

Volume 45, Issue 5, Pages (November 2016)
by Juan C. Rodríguez-Alba, Miguel E
Volume 36, Issue 6, Pages (June 2012)
Surrogate-Light-Chain Silencing Is Not Critical for the Limitation of Pre-B Cell Expansion but Is for the Termination of Constitutive Signaling  Pieter.
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
Volume 27, Issue 1, Pages (July 2007)
Volume 29, Issue 6, Pages (December 2008)
The Juxtamembrane Wedge Negatively Regulates CD45 Function in B Cells
Volume 22, Issue 2, Pages (February 2005)
Volume 38, Issue 3, Pages (March 2013)
Volume 36, Issue 6, Pages (June 2012)
Volume 35, Issue 1, Pages (July 2011)
Balthazar B Cazac, Jürgen Roes  Immunity 
Volume 11, Issue 6, Pages (June 2012)
Volume 15, Issue 6, Pages (December 2001)
Volume 24, Issue 3, Pages (March 2006)
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Volume 26, Issue 5, Pages (May 2007)
Volume 24, Issue 5, Pages (May 2006)
Volume 32, Issue 2, Pages (February 2010)
Volume 36, Issue 6, Pages (June 2012)
CD22 is a negative regulator of B-cell receptor signalling
Volume 31, Issue 2, Pages (August 2009)
Volume 34, Issue 5, Pages (May 2011)
The Physiologic Role of CD19 Cytoplasmic Tyrosines
A Two-Step Process for Thymic Regulatory T Cell Development
Manfred Kraus, Kaoru Saijo, Raul M Torres, Klaus Rajewsky  Immunity 
Regulation of BCR Signal Transduction in B-1 Cells Requires the Expression of the Src Family Kinase Lck  Joseph M. Dal Porto, Kathy Burke, John C. Cambier 
Novel Role of the Ras Cascade in Memory B Cell Response
Volume 25, Issue 5, Pages (November 2006)
B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells  Wei Luo, Florian.
Volume 28, Issue 5, Pages (May 2008)
Volume 17, Issue 1, Pages (September 2016)
Volume 39, Issue 6, Pages (December 2013)
Volume 29, Issue 1, Pages (July 2008)
Fluorescent In Vivo Detection Reveals that IgE+ B Cells Are Restrained by an Intrinsic Cell Fate Predisposition  Zhiyong Yang, Brandon M. Sullivan, Christopher D.C.
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Monte M. Winslow, Elena M. Gallo, Joel R. Neilson, Gerald R. Crabtree 
Volume 35, Issue 5, Pages (November 2011)
Volume 28, Issue 4, Pages (April 2008)
Volume 32, Issue 5, Pages (May 2010)
Volume 38, Issue 3, Pages (March 2013)
Volume 32, Issue 4, Pages (April 2010)
Volume 36, Issue 6, Pages (June 2012)
Volume 19, Issue 4, Pages (October 2003)
Volume 27, Issue 3, Pages (September 2007)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Volume 26, Issue 1, Pages (January 2007)
Volume 32, Issue 3, Pages (March 2010)
Volume 25, Issue 1, Pages (July 2006)
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
CD44 Regulates Survival and Memory Development in Th1 Cells
Volume 42, Issue 4, Pages (April 2015)
Volume 12, Issue 2, Pages (July 2015)
Identification of Anergic B Cells within a Wild-Type Repertoire
Volume 14, Issue 1, Pages (January 2001)
Volume 25, Issue 3, Pages (September 2006)
Volume 16, Issue 10, Pages (September 2016)
Volume 28, Issue 5, Pages (May 2008)
Volume 33, Issue 1, Pages (July 2010)
The Coinhibitory Receptor CTLA-4 Controls B Cell Responses by Modulating T Follicular Helper, T Follicular Regulatory, and T Regulatory Cells  Peter T.
Volume 31, Issue 5, Pages (November 2009)
Volume 23, Issue 8, Pages (May 2018)
The Role of Erk1 and Erk2 in Multiple Stages of T Cell Development
Volume 28, Issue 1, Pages (January 2008)
Volume 25, Issue 4, Pages (October 2006)
Volume 13, Issue 21, Pages (October 2003)
Presentation transcript:

Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu, Arthur Weiss  Immunity  Volume 45, Issue 6, Pages 1232-1244 (December 2016) DOI: 10.1016/j.immuni.2016.10.013 Copyright © 2016 Elsevier Inc. Terms and Conditions

Immunity 2016 45, 1232-1244DOI: (10.1016/j.immuni.2016.10.013) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Impaired TI Responses in CD148-Deficient Mice (A) Pneumovax 23-specific serum IgM titers after i.p. immunization. (B) NP-specific serum IgM after i.p. immunization with NP-ficoll. (C) NP-specific serum IgM responses in mice after i.p. immunization with NP-LPS. (D) NP-specific serum IgG1 responses in mice immunized i.p. with NP-KLH in alum. n = 5 wild-type (WT) mice, n = 4–5 PtprjTM−/TM− (PtprjTM−/TM−) mice. Each symbol represents an individual. Titer was determined at half of the maximal OD for the assay or in the linear rage of the assay, as stated. Data are representative of two (A), four (B), two (C), and three (D) experiments. p values were calculated using Mann-Whitney t test. See also Figures S1 and S2. Immunity 2016 45, 1232-1244DOI: (10.1016/j.immuni.2016.10.013) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 CD148-Mediated TI Defect Is B1 B Cell Intrinsic (A) NP-specific IgM (left) and IgG3 (right) in WT and PtprjTM−/TM− mice immunized i.v. with NP-ficoll. (B) Pneumovax 23-specific IgM titers in PtprjTM-fl/TM-fl and PtprjTM-fl/TM-flCd79a-cre mice after i.p. immunization. Titer was determined at the linear range of the assay (OD 0.3). For (A), n = 6 wild-type mice, n = 6 PtprjTM−/TM− mice. For (B), n = 5 PtprjTM-fl/TM-fl mice, n = 4 PtprjTM-fl/TM-flCd79a-cre mice. Data are representative of two (A) and three (B) experiments. Mann-Whitney t test was used to calculate p values. See also Figure S3. Immunity 2016 45, 1232-1244DOI: (10.1016/j.immuni.2016.10.013) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 Impaired Antigen-Specific Proliferation of CD148-Deficient B1 B Cells (A) Intracellular staining of peritoneal B1 (CD19+CD23−CD5+/lo) and B2 (CD19+CD23+CD5−) B cells for Ki-67 and surface NP-PE in mice 4 days after i.p. immunization with NP-ficoll. Cell counts represent the total number of events in the NP+Ki-67+ gate of each sample. (B) Quantification of NP-PE+Ki67+ peritoneal (PerC) B cells in (A) and splenic follicular (CD19+CD23+CD21−) and MZ (CD19+CD23−CD21+) B cells. Data depict the number of NP-PE+Ki-67+ cells present per 105 cells of each B cell subset. (C) ELISpot analysis of NP-specific IgM secreting cells from mice 7 days after i.p. immunization with NP-ficoll. (D) Quantification of ASCs in (C). Each symbol represents an individual mouse and is the mean of triplicate samples. For (A) and (B), data are representative of n = 12 wild-type mice and n = 12 PtprjTM−/TM− NP-ficoll immunized mice, and n = 7 wild-type mice and n = 7 PtprjTM−/TM− PBS control mice from 4 pooled experiments. For (C) and (D), data are representative of 5 independent experiments with n = 3 mice in each experimental group at either day 4 or day 7 after immunization, which give similar results. Bars represent the mean. ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001. See also Figure S4. Immunity 2016 45, 1232-1244DOI: (10.1016/j.immuni.2016.10.013) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 4 CD148 Is Required for Normal B1 B Cell Repertoire Development (A) Representative plots of flow cytometric analysis of NP-PE reactive peritoneal B cells. (B) Quantification of data depicted in (A). (C) Flow cytometric analysis of peritoneal B1 B cells from B1-8i and B1-8i-PtprjTM−/TM−, wild-type, and PtprjTM−/TM− mice. (D) Quantification of peritoneal B cell subsets in B1-8i and B1-8i-PtprjTM−/TM−, wild-type, and PtprjTM−/TM− mice. Bars represent the mean frequencies ± SEM of each B cell subpopulation as a percent of total B cells (CD19+ lymphocytes). (E) Flow cytometric analysis of κ- and λ-expressing B1 and B2 B cells in B1-8i and B1-8i-PtprjTM−/TM− mice. (F) Quantification of percent κ- and λ-expressing B1a, B1b, and B2 B cells in B1-8i and B1-8i-PtprjTM−/TM− mice. Data in (A) are representative of four mice of each genotype from two independent experiments; in (B), data show n = 4 of each wild-type and PtprjTM−/TM− mice, representative of two independent experiments. For (C) and (D), data show n = 9 of each B1-8i, B1-8i-PtprjTM−/TM−, wild-type, and PtprjTM−/TM− mice. For (E) and (F), data are representative of n = 4 of each B1-8i and B1-8i-PtprjTM−/TM− mice. Student’s t test was used to calculate p values. ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗∗p ≤ 0.0001. See also Figure S5. Immunity 2016 45, 1232-1244DOI: (10.1016/j.immuni.2016.10.013) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 5 Impaired SFK-Mediated BCR Signaling in CD148-Deficient B1 B Cells (A) Peritoneal B1 B cells (B220loCD23−CD5+/lo) stimulated for 2 min with indicated concentrations of F(ab’)2 anti-μ or 50 ng/mL phorbol myristate acetate (PMA) and stained with anti-phospho-Erk (pErk) antibody. (B) Peritoneal B1 B cells stimulated with 5 μg/mL of F(ab’)2 anti-μ for the indicated times and stained as in (A). Shaded histograms indicate unstimulated cells. (C) Percentages of pErk+ B1 B cells shown over time after stimulation with 5 μg/mL F(ab’)2 anti-μ. (D) Percentages of pErk+ follicular B cells (B220+CD23+CD21−) and MFI of pErk+ MZ B cells (B220+CD23−CD21+) over time after stimulation with 10 μg/mL F(ab’)2 anti-μ. (E) Total peritoneal lymphocytes or splenocytes loaded with Indo-1 and stained with anti-IgM Fab and dump stain to exclude non-B cells or peritoneal B2 B cells. Peritoneal cells and splenocytes were stimulated with the indicated concentrations of F(ab’)2 anti-μ (closed arrow), followed by 1 nM ionomycin (open arrow). (F) Peritoneal lymphocytes stimulated for the indicated times with 1 μg/mL NP-18-ficoll. (G) Calcium mobilization of peritoneal B1 B cells stimulated with 5 μg/mL F(ab’)2 anti-μ with or without 3 μM PP2. For (A) and (B), data are representative of seven individual experiments. For (C) and (D), n = 7 each of wild-type and PtprjTM−/TM− mice. B1 and follicular B cells respond in a bimodal fashion, so percent pErk+ cells are shown in (C) and (D); pErk induction in MZ B cells is associated with a population shift, so mean fluorescence intensity (MFI) of the population is shown. Data in (E), (F), and (G) are representative of three individual experiments with similar results. Data are expressed as mean ± SEM. Student’s t test was used to calculate p values. ∗p ≤ 0.05, ∗∗p ≤ 0.01. See also Figure S6. Immunity 2016 45, 1232-1244DOI: (10.1016/j.immuni.2016.10.013) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 6 Impaired Lyn Activation in CD148-Deficient B1 B Cells (A) Peritoneal B1 B cells stimulated with 5 μg/mL of F(ab’)2 anti-μ for the indicated times followed by intracellular staining for phospho-CD79A and surface markers. Data are expressed as mean ± SEM; histograms depict phosphorylation at time of peak signal (indicated); numbers represent MFI. (B–D) B1 B cells as in (A) stained with phospho-Syk (Y182) (B), phospho-BLNK (Y352) (C), and phospho-PLCγ2 (Y759) (D). (E) Sort-purified peritoneal B1 B cells stimulated with 5 μg/mL of F(ab’)2 anti-μ. Lysates were blotted with anti-phospho-Src antibody against the activating tyrosine of SFKs (Y416). Total Erk1 was used as a loading control. (F) Cell lysates from sort-purified peritoneal B1 and purified lymph node follicular B cells stimulated as in (E) and blotted for the inhibitory phosphotyrosine of SFK using anti-phospho-Lyn (Y507), which may cross react with other SFKs. Total Lyn was used as a loading control, for B1 B cells anti-Lyn 44 (Santa Cruz), which recognizes both Lyn isoforms was used, and anti-Lyn (Cell Signaling) was used for follicular B cells. For (A)–(D) and (F), mean MFI ± SEM is shown for each time point. For (A) an average of six experiments is shown, three experiments in (B) and (C), and four experiments in (D). A representative of three individual blots is shown for (E) and (F). ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001. Immunity 2016 45, 1232-1244DOI: (10.1016/j.immuni.2016.10.013) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 7 B1 BCR Signaling Requires Lyn Kinase (A) Intracellular pErk staining of peritoneal B1 B cells and splenic follicular B cells from wild-type and Lyn−/− mice stimulated with 5 and 10 μg/mL F(ab’)2 anti-μ, respectively. (B) Summary data of percent pErk+ B1 cells shown over time after stimulation with 5 μg/mL of F(ab’)2 anti-μ as in (A). (C) Intracellular pErk staining of peritoneal B1 B cells and splenic follicular B cells using wild-type, PtprjTM−/TM−, Lyn−/−, and Lyn−/−PtprjTM−/TM− mice stimulated with 5 and 10 μg/mL F(ab’)2 anti-μ, respectively. (D) Summary data of percent pErk+ B1 B cells from Lyn−/− and Lyn−/−PtprjTM−/TM− mice over time after stimulation with 5 μg/mL F(ab’)2 anti-μ as in (C). Data in (A) are representative of four independent experiments. For (B), n = 4 wild-type and n = 4 Lyn−/− mice. Data in (C) are representative of six independent experiments with like results. In (D), n = 6 Lyn−/− and n = 6 Lyn−/−PtprjTM−/TM−. ∗p ≤ 0.05, ∗∗∗p ≤ 0.001, ∗∗∗∗p ≤ 0.0001. Immunity 2016 45, 1232-1244DOI: (10.1016/j.immuni.2016.10.013) Copyright © 2016 Elsevier Inc. Terms and Conditions